An Unexpected Interaction between Sofosbuvir/Ledipasvir and Atorvastatin and Colchicine Causing Rhabdomyolysis in a Patient with Impaired Renal Function

Hepatitis C virus (HCV) infection affects roughly 170 million people worldwide. Sofosbuvir/Ledipasvir (Sof/Led) is a new once daily direct acting antiviral combination pill that was approved in October 2014 for use in patients with HCV genotype 1 infection. Coadministration of Sof/Led is studied onl...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Shyam, Andres, Jennifer, Qureshi, Kamran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011228/
https://www.ncbi.nlm.nih.gov/pubmed/27635145
http://dx.doi.org/10.1155/2016/3191089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011228/
https://www.ncbi.nlm.nih.gov/pubmed/27635145
http://dx.doi.org/10.1155/2016/3191089

Ejemplares similares